Qnasl and Dexilant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Qnasl (beclomethasone dipropionate) and Dexilant (dexlansoprazole). Common drug interactions include sleep apnoea syndrome among females and abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Qnasl and Dexilant. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Qnasl?

Qnasl has active ingredients of beclomethasone dipropionate. It is often used in allergies. eHealthMe is studying from 1,984 Qnasl users. Check the latest studies of Qnasl.

What is Dexilant?

Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

90 people who take Qnasl and Dexilant together, and have interactions are studied.

What are the common drug interactions of Qnasl and Dexilant, by gender? *:

female:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Therapeutic response unexpected
Weight increased
Wound infection
Sinusitis (inflammation of sinus)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Nasopharyngitis (inflammation of the nasopharynx)
Weight decreased
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Scar

male:

Abscess (pus)
Abscess limb (limb infection)
Tooth abscess (pus formation in tooth)
Urinary tract infection
Drug ineffective
Erythema (redness of the skin)
Sensation of pressure
Tongue discolouration (colour change of tongue)
Chills (felling of cold)
Decreased appetite

What are the common drug interactions of Qnasl and Dexilant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Retinal dystrophy (progressive weakness and wasting of the retina)

40-49:

Abscess limb (limb infection)
Anal abscess
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cellulitis (infection under the skin)
Dyspnoea (difficult or laboured respiration)
Erythrasma (skin disease that causes brown, scaly skin patches)
Groin abscess (pus in groin)
Perirectal abscess
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Rectal abscess (pus in rectum)

50-59:

Sinusitis (inflammation of sinus)
Abscess (pus)
Infusion site abscess
Nasopharyngitis (inflammation of the nasopharynx)
Scar
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Fall
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hordeolum (small collection of pus (abscess) on the eyelid)
Infusion site pruritus (severe itching at infusion site)

60+:

Weight decreased
Sinusitis (inflammation of sinus)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Hypotension (abnormally low blood pressure)
Infection
Intestinal obstruction
Iritis (painful inflammation of the iris of the eye)
Ocular hypertension (intraocular pressure higher than normal)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Pulmonary thrombosis (scarring in the lungs)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 32 people, 35.56%
Immunodeficiency Common Variable: 25 people, 27.78%
Asthma: 18 people, 20.00%
Immunodeficiency: 16 people, 17.78%
Primary Immunodeficiency Syndrome: 11 people, 12.22%
Sinusitis (inflammation of sinus): 7 people, 7.78%
Hypersensitivity: 6 people, 6.67%
Stress And Anxiety: 5 people, 5.56%
Sinusitis Fungal (fungal infection of sinus): 5 people, 5.56%
Sinus Disorder (disease of sinus): 5 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Qnasl and Dexilant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously